Kyo Michihito, Ohshimo Shinichiro, Kida Yoshiko, Shimatani Tatsutoshi, Torikoshi Yusuke, Suzuki Kei, Yamaga Satoshi, Hirohashi Nobuyuki, Shime Nobuaki
Department of Emergency and Critical Care Medicine, Graduate School of Biomedical Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
BMC Pulm Med. 2016 Aug 12;16(1):119. doi: 10.1186/s12890-016-0280-7.
Venoarterial-venous extracorporeal membrane oxygenation (VAV ECMO) configuration is a combined procedure of extracorporeal membrane oxygenation (ECMO). The proportion of cardiac and respiratory support can be controlled by adjusting arterial and venous return. Therefore, VAV ECMO can be applicable as a bridging therapy in the transition from venoarterial (VA) to venovenous (VV) ECMO.
We present an 11-year-old girl with chemotherapy-induced myocarditis requiring extracorporeal cardiorespiratory support. She showed progressive hypotension, tachycardia, hyperlactemia, and tachypnea under support of catecholamines. Echocardiography showed severe left ventricular hypokinesis with an ejection fraction of 30 %. She was placed on VA ECMO with a drainage catheter from the right femoral vein (19.5 Fr) and a return catheter to the right femoral artery (16.5 Fr). Extracorporeal circulation was initiated at a blood flow of 2.0 L/min (59 mL/kg/min). On day 31, although cardiac function had improved, persistent pulmonary failure made weaning from VA ECMO difficult. We planned transition from VA ECMO to VAV ECMO to ensure gradual tapering of extracorporeal cardiac support while evaluating cardiopulmonary function. An additional return cannula (13.5 Fr) was inserted from the right internal jugular vein, which was connected to the circuit branch from the original returning cannula. We then gradually shifted the blood from the femoral artery to the right internal jugular vein over 24 h. She was successfully switched from VA to VV ECMO via VAV ECMO.
VAV ECMO might be an option in ensuring oxygenation to the coronary circulation and allowing time to adequately evaluate cardiac function during transition from VA to VV ECMO. Further investigations using larger cohorts are necessary to validate the efficacy of VAV ECMO as a bridging therapy in the transition from VA to VV ECMO.
静脉-动脉-静脉体外膜肺氧合(VAV ECMO)配置是体外膜肺氧合(ECMO)的一种联合操作。心脏和呼吸支持的比例可通过调节动脉和静脉回血来控制。因此,VAV ECMO可作为从静脉-动脉(VA)到静脉-静脉(VV)ECMO过渡的桥接治疗方法。
我们报告一名11岁患化疗诱导性心肌炎的女孩,需要体外心肺支持。在儿茶酚胺支持下,她出现进行性低血压、心动过速、高乳酸血症和呼吸急促。超声心动图显示左心室严重运动减弱,射血分数为30%。她接受了VA ECMO治疗,采用一根经右股静脉的引流导管(19.5 Fr)和一根经右股动脉的回血导管(16.5 Fr)。体外循环以2.0 L/min(59 mL/kg/min)的血流量启动。在第31天,尽管心脏功能有所改善,但持续的肺功能衰竭使撤离VA ECMO变得困难。我们计划从VA ECMO过渡到VAV ECMO,以确保在评估心肺功能的同时逐渐减少体外心脏支持。从右颈内静脉插入一根额外的回血插管(13.5 Fr),并将其连接到原回血插管的回路分支。然后在24小时内将血液从股动脉逐渐转移至右颈内静脉。她成功地通过VAV ECMO从VA ECMO转换为VV ECMO。
VAV ECMO可能是一种在从VA ECMO过渡到VV ECMO期间确保冠状动脉循环氧合并留出时间充分评估心脏功能的选择。需要使用更大队列进行进一步研究,以验证VAV ECMO作为从VA到VV ECMO过渡的桥接治疗方法的有效性。